Translational Sciences (United States)

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 10 of 73 papers

  • Open Access
  • Research Article

Arsenic Trioxide Underpins Delayed Neuroinflammation and Impaired Synaptic Integrity involving Integrative Stress Response Signaling

  • Dec 02, 2025
  • bioRxiv
  • Jasim Khan +6
  • Open Access
  • Abstract
  • Citations11

877P Exploratory efficacy and translational results from the safety run in of AHEAD-MERIT, a phase II trial of first line pembrolizumab plus the fixed-antigen cancer vaccine BNT113 in advanced HPV16+ HNSCC

  • Sep 01, 2024
  • Annals of Oncology
  • N.f Saba +19
  • Abstract

1182P Determination of tumor PSMA expression in prostate cancer from blood using a novel epigenomic liquid biopsy platform

  • Sep 01, 2024
  • Annals of Oncology
  • P Ravi +19
  • Open Access
  • PDF
  • Research Article
  • Citations14

First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-β receptor I inhibitor, in patients with advanced solid tumors

  • Apr 10, 2024
  • BMC Cancer
  • Ye Guo +17
  • Open Access
  • Research Article
  • Citations17

Discovery of U2AF1 neoantigens in myeloid neoplasms

  • Dec 01, 2023
  • Journal for ImmunoTherapy of Cancer
  • Melinda Ann Biernacki +12
  • Open Access
  • Abstract
  • Citations1

1017O NTC-001: A phase I study to test safety and efficacy of BNT221, a non-engineered neoantigen-specific T cell product, in patients with advanced or metastatic melanoma

  • Oct 01, 2023
  • Annals of Oncology
  • J.s.w Borgers +13
  • Research Article
  • Citations14

Epigenetic regulation of temozolomide resistance in human cancers with an emphasis on brain tumors: Function of non-coding RNAs

  • Jul 25, 2023
  • Biomedicine & Pharmacotherapy
  • Aryan Rezaee +17
  • Book Chapter

MicroRNAs (miRNAs) in therapy response of human cancers: Biological aspects

  • Apr 01, 2023
  • Mahshid Deldar Abad Paskeh +4
  • Abstract

IDF2022-0687 Characterization and efficacy of GNTI-122, a novel engineered regulatory T-cell therapy, for treating Type 1 Diabetes

  • Mar 01, 2023
  • Diabetes Research and Clinical Practice
  • G Uenishi +9
  • Open Access
  • PDF
  • Research Article
  • Citations1

Experiences with and impacts of the COVID-19 pandemic by substance use disorder in the early phase of pandemic in the United States: A cross-sectional survey, 2020.

  • Jul 21, 2022
  • PloS one
  • Andrea Acevedo +5
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.